436 related articles for article (PubMed ID: 17053394)
21. Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: clinical use and limits.
Toubert ME; Cyna-Gorse F; Zagdanski AM; Noel-Wekstein S; Cattan P; Billotey C; Sarfati E; Rain JD
Thyroid; 1999 Jun; 9(6):591-7. PubMed ID: 10411122
[TBL] [Abstract][Full Text] [Related]
22. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
24. [Outcome in cervical recurrences of papillary or follicular thyroid cancer].
Mirallié E; Hamy A; Floch I; Sagan C; Paineau J; Murat A; Le Néel JC; Visset J
Ann Chir; 1999; 53(7):577-82. PubMed ID: 10520496
[TBL] [Abstract][Full Text] [Related]
25. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma.
Khan S; Dunn J; Strickland N; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186
[TBL] [Abstract][Full Text] [Related]
26. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
28. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment.
Soydal C; Araz M; Ozkan E; Arslantaş E; Kucuk ON; Aras G
Nucl Med Commun; 2015 Feb; 36(2):109-13. PubMed ID: 25321158
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer.
Ahn BC; Lee SW; Lee J; Kim C
Thyroid; 2011 May; 21(5):555-8. PubMed ID: 21449768
[TBL] [Abstract][Full Text] [Related]
30. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V
J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486
[TBL] [Abstract][Full Text] [Related]
31. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
[TBL] [Abstract][Full Text] [Related]
32. The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer.
Chen MK; Yasrebi M; Samii J; Staib LH; Doddamane I; Cheng DW
Thyroid; 2012 Mar; 22(3):304-9. PubMed ID: 22300251
[TBL] [Abstract][Full Text] [Related]
33. Sialadenitis mimicking metastatic thyroid carcinoma.
Kolla IS; Alazraki NP; Watts NB
Clin Nucl Med; 1989 Aug; 14(8):564-6. PubMed ID: 2805535
[TBL] [Abstract][Full Text] [Related]
34. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
35. False-positive uptake of 124I in a laryngeal cyst mimicking thyroid remnant after thyroidectomy and 131i therapy for follicular thyroid carcinoma.
Noordman BJ; Comans E; Lips P; Rinkel RN
Clin Nucl Med; 2014 Oct; 39(10):898-9. PubMed ID: 24561682
[TBL] [Abstract][Full Text] [Related]
36. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates.
Karam M; Gianoukakis A; Feustel PJ; Cheema A; Postal ES; Cooper JA
Nucl Med Commun; 2003 May; 24(5):489-95. PubMed ID: 12717064
[TBL] [Abstract][Full Text] [Related]
37. Frontal sinus mucocele mimicking a metastasis of papillary thyroid carcinoma.
Matheja P; Lerch H; Schmid KW; Kuwert T; Schober O
J Nucl Med; 1997 Jul; 38(7):1022-4. PubMed ID: 9225783
[TBL] [Abstract][Full Text] [Related]
38. Radioiodine accumulation in a large adnexal cystadenofibroma.
Turker O; Dogan I; Kumanlioglu K
Thyroid; 2010 May; 20(5):561-2. PubMed ID: 20406107
[TBL] [Abstract][Full Text] [Related]
39. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
[TBL] [Abstract][Full Text] [Related]
40. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
